EARLY BUILD · 15 license-and-service checked provider listings · No patient data collected
← Compound library
Investigational / no FDA-approved-treatment claim

AICAR (related non-peptide)

A metabolic research compound often described as an exercise mimetic.

Regulatory status and key limits

Investigational / no FDA-approved-treatment claim

A metabolic research compound often described as an exercise mimetic.

Reviewed October 10, 2026. Product and route distinctions stay attached to the source; this is not a treatment recommendation.

Source checked October 10, 2026 · Editorial source review · Not medical advice
No dosing or purchase guidance. This information is not a recommendation to use a compound.

Purported uses, not established benefits

Proponents claim AICAR may reproduce aspects of exercise signaling and improve endurance.

The cited Cell study investigated AMPK activation and endurance in mice. This does not establish safe human athletic enhancement or a replacement for exercise.

A claimed use is not proof of safety, effectiveness or FDA approval. Research-purpose-only labeling does not authorize human use.

Evidence and source limits

The source linked here describes research or investigational use. It does not establish an FDA-approved indication for this compound or for a research-chemical product. A claimed use is not an established benefit.

Product identity, purity, route, safety and suitability remain separate questions. Research-purpose-only labeling does not authorize human use. This note provides no dosing, preparation or purchase guidance.

Original source

Original source: AICAR (related non-peptide) ↗

Interpretation is limited to the source linked above. Educational source review, not independent medical review. No dosing, preparation instructions, seller links or treatment endorsement.